Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2023, Vol. 19 ›› Issue (04): 487 -491. doi: 10.3877/cma.j.issn.1673-5250.2023.04.015

Review

Treatment and management of pituitary tumor during pregnancy

Chenxi Ran, Rufei Shen, Mingyu Liao, Qian Liao, Ling Zhou, Yuling Zhang, Min Long()   

  1. Department of Endocrinology, The Second Affiliated Hospital (Xinqiao Hospital) of Army Medical University, Chongqing 400037, China
    Department of Endocrinology, The First Affiliated Hospital (Xinan Hospital) of Army Medical University, Chongqing 400037, China
  • Received:2023-03-25 Revised:2023-06-23 Published:2023-08-01
  • Corresponding author: Min Long
  • Supported by:
    Chongqing Young and Middle-aged Medical Talents Project(20220505)

During pregnancy, there will be significant changes in endogenous hormones level, and pituitary tissues are susceptible to these changes. For women with pituitary tumor, changes in pituitary hormones during pregnancy will not only increase the risk of tumor growth, but also affect the health status of them and their fetuses. Different treatments or interventions during pregnancy can also affect the natural course of pregnancy in patients with pituitary tumors. The specificity of pregnancy status makes the diagnosis of pituitary tumors during pregnancy challenging, which leads to an increase in adverse pregnancy outcomes secondary to abnormal pituitary hormone levels such as prolactin, growth hormone, cortisol, etc.. Therefore, the diagnosis, treatments and follow-up of pituitary tumors during pregnancy are very important. This article focuses on analyzing the pregnancy characteristics and precautions of patients with various types of pituitary tumors, in order to provide guidance for the individualized management of such patients during pregnancy.

[1]
Luger A, Broersen LA, Biermasz NR, et al. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy[J]. Eur J Endocrinol, 2021, 185(3): G1-G33. DOI: 10.1530/EJE-21-0462.
[2]
Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO classification of pituitary tumors[J]. Endocr Pathol, 2022, 33(1): 6-26. DOI: 10.1007/s12022-022-09703-7.
[3]
Valassi E. Pituitary disease and pregnancy[J]. Endocrinol Diabetes Nutr (Engl Ed), 2021, 68(3): 184-195. DOI: 10.1016/j.endien.2020.07.002.
[4]
Glezer A, Bronstein MD. Prolactinomas in pregnancy: considerations before conception and during pregnancy[J]. Pituitary, 2020, 23(1): 65-69. DOI: 10.1007/s11102-019-01010-5.
[5]
Kuhn E, Weinreich AA, Biermasz NR, et al. Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature[J]. Eur J Endocrinol, 2021, 185(1): 99-108. DOI: 10.1530/EJE-21-0145.
[6]
Petersenn S. Management des prolaktinoms vor, während und nach der schwangerschaft [Management of prolactinoma prior to, during, and after pregnancy][J]. Dtsch Med Wochenschr, 2023, 148(7): 371-379. DOI: 10.1055/a-1847-2500.
[7]
Barraud S, Guédra L, Delemer B, et al. Evolution of macroprolactinomas during pregnancy: a cohort study of 85 pregnancies[J]. Clin Endocrinol (Oxf), 2020, 92(5): 421-427. DOI: 10.1111/cen.14162.
[8]
Levin G, Rottenstreich A. Prolactin, prolactin disorders, and dopamine agonists during pregnancy[J]. Hormones (Athens), 2019, 18(2): 137-139. DOI: 10.1007/s42000-018-0071-z.
[9]
Pasyechko N, Naumova L, Krytskyy T, et al. Successful treatment of a prolactinoma (case report)[J]. Georgian Med Issues, 2019(287): 26-29.
[10]
Sant′ Anna BG, Musolino NRC, Gadelha MR, et al. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas[J]. Pituitary, 2020, 23(2): 120-128. DOI: 10.1007/s11102-019-01008-z.
[11]
List EO, Berryman DE, List BP, et al. Early investigations of 20-kDa human placental GH show promise[J]. Endocr Metab Immune Disord Drug Targets, 2023 May 15. DOI: 10.2174/1871530323666230515153130. Online ahead of print.
[12]
Bandeira DB, Olivatti TOF, Bolfi F, et al. Acromegaly and pregnancy: a systematic review and Meta-analysis[J]. Pituitary, 2022, 25(3): 352-362. DOI: 10.1007/s11102-022-01208-0.
[13]
Vialon M, Grunenwald S, Mouly C, et al. Gestational diabetes and acromegaly: single-centre experience of 14 pregnancies[J]. Clin Endocrinol (Oxf), 2019, 91(6): 805-809. DOI: 10.1111/cen.14097.
[14]
Popescu AD, Carsote M, Valea A, et al. Approach of acromegaly during pregnancy[J]. Diagnostics (Basel), 2022, 12(11): 2669. DOI: 10.3390/diagnostics12112669.
[15]
Chanson P, Vialon M, Caron P. An update on clinical care for pregnant women with acromegaly[J]. Expert Rev Endocrinol Metab, 2019, 14(2): 85-96. DOI: 10.1080/17446651.2019.1571909.
[16]
Huang W, Molitch ME. Pituitary tumors in pregnancy[J]. Endocrinol Metab Clin North Am, 2019, 48(3): 569-581. DOI: 10.1016/j.ecl.2019.05.004.
[17]
Petersenn S, Christ-Crain M, Droste M, et al. Pituitary disease in pregnancy: special aspects of diagnosis and treatment?[J]. Geburtshilfe Frauenheilkd, 2019, 79(4): 365-374. DOI: 10.1055/a-0794-7587.
[18]
Jolly K, Darr A, Arlt W, et al. Surgery for Cushing′s disease in pregnancy: our experience and a literature review[J]. Ann R Coll Surg Engl, 2019, 101(1): e26-e31. DOI: 10.1308/rcsann.2018.0175.
[19]
Hamblin R, Coulden A, Fountas A, et al. The diagnosis and management of Cushing′s syndrome in pregnancy[J]. J Neuroendocrinol, 2022, 34(8): e13118. DOI: 10.1111/jne.13118.
[20]
Brue T, Amodru V, Castinetti F. Management of endocrine disease: management of Cushing′s syndrome during pregnancy: solved and unsolved questions[J]. Eur J Endocrinol, 2018, 178(6): R259-R266. DOI: 10.1530/EJE-17-1058.
[21]
Patel MA, Aliporewala VM, Patel DA. Common antifungal drugs in pregnancy: risks and precautions[J]. J Obstet Gynaecol India, 2021, 71(6): 577-582. DOI: 10.1007/s13224-021-01586-8.
[22]
Chaiamnuay S, Moster M, Katz MR, et al. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy[J]. Pituitary, 2003, 6(2): 109-113. DOI: 10.1023/b:pitu.0000004802.47010.00.
[23]
Woodmansee WW. Pituitary disorders in pregnancy[J]. Neurol Clin, 2019, 37(1): 63-83. DOI: 10.1016/j.ncl.2018.09.009.
[24]
Blackhurst G, Strachan MW, Collie D, et al. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy[J]. Clin Endocrinol (Oxf), 2002, 57(3): 401-404. DOI: 10.1046/j.1365-2265.2002.01549.x.
[25]
Barsi á, Beke A, Sármán B. Case report: a particularly rare case of endogenous hyperinsulinemic hypoglycemia complicated with pregnancy treated with short-acting somatostatin analog injections[J]. Front Endocrinol (Lausanne), 2022, 13: 964481. DOI: 10.3389/fendo.2022.964481.
[26]
Deutschbein T, Jaursch-Hancke C, Knappe UJ, et al. First german guideline on diagnostics and therapy of clinically non-functioning pituitary tumors[J]. Exp Clin Endocrinol Diabetes, 2021, 129(3): 250-264. DOI: 10.1055/a-1373-4087.
[27]
Karaca Z, Yarman S, Ozbas I, et al. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey[J]. J Endocrinol Invest, 2018, 41(1): 129-141. DOI: 10.1007/s40618-017-0709-8.
[28]
Rosmino J, Tkatch J, Di Paolo MV, et al. Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature[J]. Arch Endocrinol Metab, 2021, 64(5): 614-622. DOI: 10.20945/2359-3997000000232.
[29]
Flitsch J, Burkhardt T. Non-functioning pituitary tumors: any special considerations during pregnancy?[J]. Minerva Endocrinol, 2018, 43(4): 430-434. DOI: 10.23736/s0391-1977.17.02784-5.
[30]
Noyola-Martínez N, Halhali A, Barrera D. Steroid hormones and pregnancy[J]. Gynecol Endocrinol, 2019, 35(5): 376-384. DOI: 10.1080/09513590.2018.1564742.
[31]
Gersh FL, Lavie CJ. Details on hormone replacement therapy[J]. Heart, 2020, 106(16): 1278-1279. DOI: 10.1136/heartjnl-2020-317044.
[1] Qianmei Li, Guannan He, Jing Zhao, Xi Chen, Yuying Tang, Liqiong Ma, Rong Liang, Tao Yuan, Mingxing Li. Placental microvascular flow imaging characteristics and prognosis of early low-risk and high-risk pregnancies[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 726-732.
[2] Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis:executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology(SIGO)[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[3] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[4] Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[5] Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[6] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[7] Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[8] Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[9] Jiangyan Xie, Yafei Wang, Fang He. Pregnancy complicated with thrombotic thrombocytopenic purpura:two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 556-563.
[10] Tingting Xu, Yongchi Zhan, Xiaodong Wang, Xiaodong Wang. Perinatal outcomes of fetomaternal hemorrhage syndrome pregnant women with sinusoidal fetal heart tracing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 382-389.
[11] Nan Li, Siqi Qiu, Mingyu Xue, Ying Zhang. Self-injurious oral lesions and related diseases management[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2024, 18(05): 307-311.
[12] Jing Zhang, Chang Liu, Chengge Hua. Progress in the treatment of oral diseases during pregnancy[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2024, 18(05): 340-344.
[13] Jingyun Xu, Bo Ding, Yuhui Jiang, Yang Shen. The practice and consideration of single-site laparoscopic operation during pregnancy[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(05): 262-266.
[14] Shan Lu, Yunshan Yao, Seni Liao, Zien Chen, Yijian Zhang, Jianhao Lan, Wei Wei, Yanyang Liu, Yanhong Chen, Duijin Chen. Clinical study of 100 cases of suspected pregnancy complicated with acute appendicitis[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 214-219.
[15] Wenyan Wang, Jianlan Zheng, Lici Zhu. Clinical study on the risk of pregnancy and perinatal period after in vitro fertilization and embryo transfe[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 220-226.
Viewed
Full text


Abstract